Transforming Drug Discovery: The Critical Role of Proteomics and Targeted Protein Degradation in the Future of Therapeutics
Introduction: A Paradigm Shift in Drug Discovery
Scientific deep dives, product thinking, and perspectives on proteomics, reproducibility, and agent-ready science — from the team building Mass Dynamics.
Introduction: A Paradigm Shift in Drug Discovery
From Left to Right: Dr Jamie Kuhar, Prof. Parag Mallick, Dr Fiona McAllister, Dr Francesco Pingitore, Assist. Prof. Ruth Huttenhain, Dr ...
It's hard to believe we're officially past the half way point of the year! Are you more than half way to achieving your goals? If you're ...
"If I have seen further, it is by standing on the shoulders of giants." Isaac Newton (1676). The scientific process of discovery is a slow ...
Technology is moving fast 💨 Here’s 'What’s New' at Mass Dynamics to help you, your team and Collaborators level-up 👀! Thank you for being ...
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization March 06, 2023 ...
Hi there!, Welcome to the final #MassGeek Playbook for the year - a HUPO 2022 Special Edition! If you are new to the MassGeek Community, ...
MD 2.0 unleashes next level MSP insight generation In my opinion, MSP is one of the most exciting areas in biological research. By allowing ...
The proteomics revolution has started. It’s going to change our understanding of how life exists and provide insights into managing – and ...
Special ASMS 2022 Edition It feels so much longer but it's only been a few days since over 5,000 delegates descended onto Minneapolis, ...